We now have a glimpse behind the curtain of how Medicare arrives at so-called maximum fair prices of prescription drugs it ...

Aardvark’s lead candidate ARD-101 is being investigated in a Phase III study for hyperphagia in Prader-Willi syndrome.

Public anger in China over concerns raised by doctors that generic drugs used in public hospitals are increasingly ...

In what appears to be a response to manufacturer complaints regarding “black box” Inflation Reduction Act (IRA) drug price negotiations, the ...

Minnesota Attorney General Keith Ellison and pharmaceutical company Novo Nordisk reached a settlement to cap insulin costs at ...

Thursday to confirm Robert F. Kennedy Jr. as Secretary of Health and Human Services, where he will oversee the nation's ...

New drugs for early Alzheimer’s disease may allow people to live without help for up to 39 additional months, a new study estimates. But experts urge caution.

CVS’s stock soared toward a three-month high after its quarterly profit beat expectations by the widest margin in more than four years.

Kiniksa Pharmaceuticals stock is attractive because it trades near 52-week lows, and its marketed drug gains traction. Click to find out why KNSA is a Hold.

In this article, we are going to take a look at where Conduit Pharmaceuticals Inc. (NASDAQ:CDT) stands against the other AI ...

They focus on the cost of the drug, but fail to consider the effectiveness ... the drug and found that it offered a noteworthy improvement over existing treatments. Not the full picture The ...